Kintara Therapeutics : TuHURA Biosciences to Present Its IFx

TuHURA Biosciences to Present Its IFx-2.0 Personalized Cancer Vaccine Clinical Trial Results at the 2024 American Society of Clinical Oncology Annual Meeting


TAMPA, FL&SAN...

Related Keywords

California , United States , Chicago , Illinois , San Diego , American , Jenene Thomas , Andrew Brohl , Roberte Hoffman , Tuhura Biosciences Inc , H Lee Moffitt Cancer Center , American Society Of Clinical Oncology , Kintara Therapeutics Inc , Exchange Commission , Linkedin , Facebook , Research Institute , Present Its , Cancer Vaccine Clinical Trial Results , Clinical Oncology , Annual Meeting , Merkel Cell Carcinoma , Cutaneous Squamous Cell Carcinoma , Moffitt Cancer Center , Skin Cancers , Kintara Therapeutics , Antibody Drug Conjugates , Nasdaq Capital Market , Merkel Cell , Myeloid Derived Suppressor Cells , Information About , Proposed Merger , Registration Statement , Annual Report , Private Securities Litigation Reform Act , Merger Agreement , Markets ,